Aandeel A004720 PHARMGEN SCIENCE, INC.
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen PharmGen Science, Inc.

Aandelen

A004720

KR7004720009

slotkoers Korea S.E.
Andere beurzen
 00:00:00 26-04-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
5.240 KRW +0,77% Intraday-grafiek van PharmGen Science, Inc. +2,34% -15,48%
2023 PharmGen Science, Inc. meldt winstresultaten voor het eerste kwartaal eindigend op 31 maart 2023 CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
PharmGen Science, Inc.(KOSE:A004720) dropped from S&P Global BMI Index
PharmGen Science, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
PharmGen Science Inc. announced that it has received KRW 20 billion in funding from Meritz Securities Co., Ltd.
PharmGen Science Inc. announced that it expects to receive KRW 20 billion in funding from Meritz Securities Co., Ltd.
PharmGen Science Inc. announced that it has received KRW 30 billion in funding from Linden Advisors LP, SC Lowy Financial (HK) Limited
PharmGen Science Inc. announced that it expects to receive KRW 30 billion in funding from Linden Advisors LP, SC Lowy Financial (HK) Limited
Wooridul Pharmaceutical Limited announced that it has received KRW 20 billion in funding from Linden Advisors LP, SC Lowy Financial (HK) Limited
MÄRKTE ASIEN/Impulsloser Handel mit wenig Bewegung bei Aktien
Wooridul Pharmaceutical Limited announced that it expects to receive KRW 20 billion in funding from Linden Advisors LP, SC Lowy Financial (HK) Limited
Wooridul Pharmaceutical Limited(KOSE:A004720) added to S&P Global BMI Index
Wooridul Pharmaceutical Limited cancelled the acquisition of 11.6% stake in Access Bio, Inc. from Youngho Choi.
HD Fund signed a stock transfer agreement to acquire 6.4% stake in Wooridul Pharmaceutical Limited from Soo-Kyung Kim for KRW 12 billion.
Access Bio, Inc. announced that it has received KRW 9.999999142 billion in funding from Wooridul Pharmaceutical Limited
Wooridul Pharmaceutical Limited signed a contract to acquire 11.6% stake in Access Bio, Inc. from Youngho Choi for KRW 17 billion.
Access Bio, Inc. announced that it expects to receive KRW 9.999999142 billion in funding from Wooridul Pharmaceutical Limited
Wooridul Pharmaceutical Limited announced that it has received KRW 20 billion in funding from Choeun Mutual Savings Bank, Investment Arm, Hana Capital Co., Ltd., and other investors
Wooridul Pharmaceutical Limited announced that it expects to receive KRW 20 billion in funding from Choeun Mutual Savings Bank, Investment Arm, Hana Capital Co., Ltd., and other investors.
Miev Co., Ltd. announced that it has received KRW 1 billion in funding from Wooridul Pharmaceutical Limited
Miev Co., Ltd. announced that it expects to receive KRW 1 billion in funding from Wooridul Pharmaceutical Limited
Wooridul Pharmaceutical Limited(KOSE:A004720) dropped from S&P Global BMI Index
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers A004720
  4. Nieuws PharmGen Science, Inc.
  5. Andere talen